Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-50.87%
↓ 107% below average
Average (39q)
773.52%
Historical baseline
Range
High:22387.63%
Low:-97.04%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -50.87% |
| Q2 2025 | 2187.32% |
| Q1 2025 | -95.25% |
| Q4 2024 | 1417.37% |
| Q3 2024 | 6.25% |
| Q2 2024 | 45.75% |
| Q1 2024 | 60.97% |
| Q4 2023 | 333.33% |
| Q3 2023 | -48.90% |
| Q2 2023 | 1220.83% |
| Q1 2023 | -14.29% |
| Q4 2022 | -28.21% |
| Q3 2022 | 11.43% |
| Q2 2022 | -5.41% |
| Q1 2022 | 164.29% |
| Q4 2021 | -39.13% |
| Q3 2021 | -90.17% |
| Q2 2021 | 766.67% |
| Q1 2021 | -86.43% |
| Q4 2020 | -97.00% |
| Q3 2020 | -27.60% |
| Q2 2020 | 14.55% |
| Q1 2020 | -8.34% |
| Q4 2019 | -97.04% |
| Q3 2019 | 2941.19% |
| Q2 2019 | 5.06% |
| Q1 2019 | -46.01% |
| Q4 2018 | 148.99% |
| Q3 2018 | -50.15% |
| Q2 2018 | -45.44% |
| Q1 2018 | -23.72% |
| Q4 2017 | 22.66% |
| Q3 2017 | 123.53% |
| Q2 2017 | -34.11% |
| Q1 2017 | -20.59% |
| Q4 2016 | -16.88% |
| Q3 2016 | 37.97% |
| Q2 2016 | 60.79% |
| Q1 2016 | -90.18% |
| Q4 2015 | 22387.63% |